SCHEMBL12017372

SCHEMBL12017372

COC(=O)c1ccc(Cc2ccc(C(C)=O)o2)o1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.86
ALDH1A1 P00352 4/20 0.58
NPSR1 Q6W5P4 1/20 0.58
RAB9A P51151 4/20 0.55
TSHR P16473 3/20 0.55
NPC1 O15118 3/20 0.55
HSP90AA1 P07900 1/20 0.55
MAPT P10636 4/20 0.54
LMNA P02545 2/20 0.54
CYP2C19 P33261 2/20 0.52
HPGD P15428 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
CYP1A2 P05177 1/20 0.51
HSD17B10 Q99714 2/20 0.51
POLB P06746 1/20 0.50
KDM4E B2RXH2 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12018996 0.93 HTT (1.00) HTTALDH1A1NPSR1RAB9ATSHR
SCHEMBL3140257 0.85 MEN1 (0.61) HTTALDH1A1NPSR1RAB9ATSHR
SCHEMBL4675811 0.81 HTT (0.77) HTTALDH1A1NPSR1RAB9ATSHR
SCHEMBL15893987 0.81 HTT (0.77) HTTALDH1A1NPSR1RAB9ATSHR
SCHEMBL2031143 0.80 HTT (0.76) HTTALDH1A1NPSR1RAB9ATSHR
SCHEMBL1530038 0.80 HTT (0.76) HTTALDH1A1NPSR1RAB9ATSHR
SCHEMBL4676184 0.80 HTT (0.75) HTTALDH1A1NPSR1RAB9ATSHR
SCHEMBL189224 0.79 HTT (0.73) HTTALDH1A1NPSR1RAB9ATSHR
SCHEMBL4444107 0.79 HTT (0.73) HTTALDH1A1NPSR1RAB9ATSHR
SCHEMBL13351840 0.79 HTT (0.53) HTTALDH1A1NPSR1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9035018-B2 Furan-based curable compound derived from biomass, solvent-free curable composition, and method for preparing same KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2015-05-19 US disclosed
US-20120220742-A1 Furan-Based Curable Compound Derived from Biomass, Solvent-Free Curable Composition, and Method for Preparing Same KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2012-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120220742-A1 Furan-Based Curable Compound Derived from Biomass, Solvent-Free Curable Composition, and Method for Preparing Same FASN, DCXR, CBR3 HTT 3995/4885ALDH1A1 2009/4885NPSR1 4823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.